You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 11, 2024

ZAROXOLYN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zaroxolyn patents expire, and when can generic versions of Zaroxolyn launch?

Zaroxolyn is a drug marketed by I3 Pharms and is included in one NDA.

The generic ingredient in ZAROXOLYN is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zaroxolyn

A generic version of ZAROXOLYN was approved as metolazone by SANDOZ on December 19th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZAROXOLYN?
  • What are the global sales for ZAROXOLYN?
  • What is Average Wholesale Price for ZAROXOLYN?
Summary for ZAROXOLYN
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 87
Clinical Trials: 7
Patent Applications: 4,019
What excipients (inactive ingredients) are in ZAROXOLYN?ZAROXOLYN excipients list
DailyMed Link:ZAROXOLYN at DailyMed
Drug patent expirations by year for ZAROXOLYN
Recent Clinical Trials for ZAROXOLYN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Maryland, BaltimorePhase 4
University of MarylandPhase 4
University of VirginiaPhase 4

See all ZAROXOLYN clinical trials

US Patents and Regulatory Information for ZAROXOLYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
I3 Pharms ZAROXOLYN metolazone TABLET;ORAL 017386-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
I3 Pharms ZAROXOLYN metolazone TABLET;ORAL 017386-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
I3 Pharms ZAROXOLYN metolazone TABLET;ORAL 017386-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.